Parenterals 2012: Contribution of Biologics to Public Health

Biotech products are playing an established role in the pharmaceutical portfolio for a number of indications. Even though high expectations into further growths have not always been met, average growths rate is still outpacing conventional products. Parenterals 2012 gives a high level perspective on contribution of biotech products to public health from an industry as well as from an authority point of view and it does provide insight into actual trends in manufacturing.

At Parenterals 2012 there will be 5 sessions:
*Impact of New Guidelines on Manufacturing
*Manufacturing Environment
*Manufacturing Technologies
*Components: Elastomers, Containers, Devices
*Efficiency, Cost & Compliance